Compare BTMD & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTMD | RMTI |
|---|---|---|
| Founded | 2012 | 1994 |
| Country | United States | United States |
| Employees | N/A | 300 |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.0M | 29.1M |
| IPO Year | 2021 | 2022 |
| Metric | BTMD | RMTI |
|---|---|---|
| Price | $0.84 | $6.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | $2.22 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 84.3K | 19.8K |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 722.22 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $192,219,000.00 | $69,258,000.00 |
| Revenue This Year | N/A | $5.09 |
| Revenue Next Year | $2.95 | $8.02 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.93 | $0.55 |
| 52 Week High | $2.90 | $8.90 |
| Indicator | BTMD | RMTI |
|---|---|---|
| Relative Strength Index (RSI) | 32.21 | 40.31 |
| Support Level | N/A | $0.78 |
| Resistance Level | $1.24 | $8.18 |
| Average True Range (ATR) | 0.09 | 0.60 |
| MACD | -0.02 | -0.10 |
| Stochastic Oscillator | 0.00 | 21.09 |
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.